Axon terminal hypertrophy of striatal projection neurons with levodopa-induced dyskinesia priming
暂无分享,去创建一个
K. Wakabayashi | F. Mori | T. Kon | M. Tomiyama | Takashi Nakamura | Chieko Suzuki | H. Nishijima | Iku Kinoshita
[1] N. Ichinohe,et al. GABA storage and release in the medial globus pallidus in L-DOPA-induced dyskinesia priming , 2020, Neurobiology of Disease.
[2] S. Ueno,et al. Zonisamide Enhances Motor Effects of Levodopa, Not of Apomorphine, in a Rat Model of Parkinson's Disease , 2018, Parkinson's disease.
[3] Ori J. Lieberman,et al. Synaptic plasticity may underlie l-DOPA induced dyskinesia , 2018, Current Opinion in Neurobiology.
[4] Susan H Fox,et al. Clinical spectrum of levodopa‐induced complications , 2015, Movement disorders : official journal of the Movement Disorder Society.
[5] D. Lindenbach,et al. Side effect profile of 5‐HT treatments for Parkinson's disease and L‐DOPA‐induced dyskinesia in rats , 2015, British journal of pharmacology.
[6] M. Cenci,et al. Ratings of L‐DOPA‐Induced Dyskinesia in the Unilateral 6‐OHDA Lesion Model of Parkinson's Disease in Rats and Mice , 2007, Current protocols in neuroscience.
[7] G. Bernardi,et al. The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy? , 2005, Trends in pharmacological sciences.
[8] K. Nielsen,et al. Normalization of glutamate decarboxylase gene expression in the entopeduncular nucleus of rats with a unilateral 6-hydroxydopamine lesion correlates with increased gabaergic input following intermittent but not continuous levodopa , 2004, Neuroscience.
[9] J. Girault,et al. Persistent Increase in Olfactory Type G-Protein α Subunit Levels May Underlie D1 Receptor Functional Hypersensitivity in Parkinson Disease , 2004, The Journal of Neuroscience.
[10] Paul Greengard,et al. Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia , 2003, Nature Neuroscience.
[11] C. Gerfen,et al. D1 Dopamine Receptor Supersensitivity in the Dopamine-Depleted Striatum Results from a Switch in the Regulation of ERK1/2/MAP Kinase , 2002, The Journal of Neuroscience.
[12] N. Wierup,et al. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease , 2002, The European journal of neuroscience.
[13] Erwan Bezard,et al. Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies , 2001, Nature Reviews Neuroscience.
[14] M. Matsunaga,et al. Activation of 5‐HT1A but not 5‐HT1B receptors attenuates an increase in extracellular dopamine derived from exogenously administered l‐DOPA in the striatum with nigrostriatal denervation , 2001, Journal of neurochemistry.
[15] B Bioulac,et al. Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey. , 2001, Brain : a journal of neurology.
[16] J A Obeso,et al. Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model. , 2000, Annals of neurology.
[17] R. Desimone,et al. Internal globus pallidus discharge is nearly suppressed during levodopa‐induced dyskinesias , 1999, Annals of neurology.
[18] T. Suda,et al. Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats. , 1999, Neuroreport.
[19] A. Lang,et al. Posteroventral medial pallidotomy in advanced Parkinson's disease. , 1997, Advances in neurology.
[20] C. Gerfen,et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. , 1990, Science.
[21] J. Penney,et al. The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.
[22] T. Boone,et al. A combined flat‐embedding, HRP histochemical method for correlative light and electron microscopic study of single neurons , 1984, Journal of neuroscience research.
[23] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .